In preclinical mouse studies, researchers observed that GLP-1 receptor activation reduced inflammation in joint tissue and showed potential to slow and in some cases partially reverse degenerative changes associated with osteoarthritis
GLP-1RAs have seen increased utilization in the management of dermatologic inflammatory diseasesin particular, psoriasis, hidradenitis suppurativa (HS), and atopic dermatitis (AD)
Med Sci J Islam Azad Univesity - Tehran Med Branch
Glucagon-like peptide-1 receptor agonists represent one such important advancement that offers multiple benefits in the management of type 2 diabetes
Compounded products do not have the same safety, quality, and effectiveness assurances as FDA-approved drugs, and adulterated and misbranded injectable compounded drugs may expose patients to significant health risks, Jason Brett, executive director of medical affairs at Novo, said in a press release
PLoS ONE 6 , e19657 (2011)